Litcius/Paper detail

Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles

Elisabetta Vergani, Adele Busico, Matteo Dugo, Andrea Devecchi, Barbara Valeri, Mara Cossa, Lorenza Di Guardo, Loris De Cecco, Erika Feltrin, Giorgio Valle, Paola Deho, Simona Frigerio, Luca Lalli, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Giancarlo Pruneri, Elena Tamborini, Licia Rivoltini, Marialuisa Sensi, Viviana Vallacchi, Monica Rodolfo

2022Journal of Investigative Dermatology14 citationsDOIOpen Access PDF

Topics & Concepts

VemurafenibDabrafenibTargeted therapyMelanomaBiologyTrametinibCancer researchMEK inhibitorExome sequencingTranscriptomeGeneCancerGeneticsKinaseMutationMAPK/ERK pathwayGene expressionMetastatic melanomaMelanoma and MAPK PathwaysColorectal Cancer Treatments and StudiesCancer Genomics and Diagnostics
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles | Litcius